R-Med OÜ

Active Registry code 14443570 OÜ Tallinn Registered 7 Mar 2018
Compare

R-Med OÜ is a OÜ based in Tallinn, registry code 14443570, status: active. Main activity: Research and experimental development on natural sciences and engineering. Its annual report for 2025 shows revenue of €9 594 and 0 employees.

Revenue
9 594 €
↑ 9.1% vs 2024
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 9 594 €
    industry median 0 € · companies in the industry: 1 073
  • Net profit margin · 2025 93.3 %
    industry median 13.5 % · companies in the industry: 597

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2018 – 2025
Revenue, € 2025: 9 594 € · +9.1% vs 2024 · industry median 0 € · above 70% of the industry
05 00010 00015 0002018 Company: — Industry median: —20182019 Company: 0 € Industry median: 0 €20192020 Company: 6 285 € Industry median: 150 €20202021 Company: 2 111 € Industry median: 0 €20212022 Company: 5 053 € Industry median: 103 €20222023 Company: 13 118 € Industry median: 76 €20232024 Company: 8 797 € Industry median: 0 €20242025 Company: 9 594 € Industry median: 0 €202505 00010 00015 0002018 Company: — Industry median: —2019 Company: 0 € Industry median: 0 €20192020 Company: 6 285 € Industry median: 150 €2021 Company: 2 111 € Industry median: 0 €20212022 Company: 5 053 € Industry median: 103 €2023 Company: 13 118 € Industry median: 76 €20232024 Company: 8 797 € Industry median: 0 €2025 Company: 9 594 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 8 951 € · +443.6% vs 2024 · industry median 0 € · above 80% of the industry
-5 00005 00010 00015 00020 0002018 Company: — Industry median: —20182019 Company: -36 € Industry median: 3 €20192020 Company: 6 187 € Industry median: 28 €20202021 Company: 2 491 € Industry median: 1 €20212022 Company: 7 247 € Industry median: 0 €20222023 Company: 16 476 € Industry median: 0 €20232024 Company: -2 605 € Industry median: 0 €20242025 Company: 8 951 € Industry median: 0 €2025-5 00005 00010 00015 00020 0002018 Company: — Industry median: —2019 Company: -36 € Industry median: 3 €20192020 Company: 6 187 € Industry median: 28 €2021 Company: 2 491 € Industry median: 1 €20212022 Company: 7 247 € Industry median: 0 €2023 Company: 16 476 € Industry median: 0 €20232024 Company: -2 605 € Industry median: 0 €2025 Company: 8 951 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 93.3 % · +122.9 pp vs the year before · industry median 13.5 % · above 92% of the industry
-500501001502018 Company: — Industry median: —20182019 Company: — Industry median: 12.7 %20192020 Company: 98.4 % Industry median: 23.8 %20202021 Company: 118.0 % Industry median: 25.1 %20212022 Company: 143.4 % Industry median: 17.7 %20222023 Company: 125.6 % Industry median: 16.8 %20232024 Company: -29.6 % Industry median: 15.8 %20242025 Company: 93.3 % Industry median: 13.5 %2025-500501001502018 Company: — Industry median: —2019 Company: — Industry median: 12.7 %20192020 Company: 98.4 % Industry median: 23.8 %2021 Company: 118.0 % Industry median: 25.1 %20212022 Company: 143.4 % Industry median: 17.7 %2023 Company: 125.6 % Industry median: 16.8 %20232024 Company: -29.6 % Industry median: 15.8 %2025 Company: 93.3 % Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 42 425 € · +26.7% vs 2024
020 00040 00060 0002018 Company: —20182019 Company: 6 180 €20192020 Company: 12 367 €20202021 Company: 19 858 €20212022 Company: 46 594 €20222023 Company: 50 119 €20232024 Company: 33 474 €20242025 Company: 42 425 €2025020 00040 00060 0002018 Company: —2019 Company: 6 180 €20192020 Company: 12 367 €2021 Company: 19 858 €20212022 Company: 46 594 €2023 Company: 50 119 €20232024 Company: 33 474 €2025 Company: 42 425 €2025
Equity, € 2025: 42 425 € · +26.7% vs 2024
010 00020 00030 00040 00050 0002018 Company: —20182019 Company: 6 180 €20192020 Company: 12 367 €20202021 Company: 14 858 €20212022 Company: 22 104 €20222023 Company: 38 579 €20232024 Company: 33 474 €20242025 Company: 42 425 €2025010 00020 00030 00040 00050 0002018 Company: —2019 Company: 6 180 €20192020 Company: 12 367 €2021 Company: 14 858 €20212022 Company: 22 104 €2023 Company: 38 579 €20232024 Company: 33 474 €2025 Company: 42 425 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02018 Company: 0 Industry median: 120182019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02018 Company: 0 Industry median: 12019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 9 594 8 951 0 42 425 42 425 0
2024 8 797 -2 605 0 33 474 33 474 0
2023 13 118 16 476 0 50 119 38 579 0
2022 5 053 7 247 0 46 594 22 104 0
2021 2 111 2 491 0 19 858 14 858 0
2020 6 285 6 187 0 12 367 12 367 0
2019 0 -36 0 6 180 6 180 0
2018 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
93.3 %
Net profit / revenue
Return on equity (ROE)
21.1 %
Net profit / equity
Return on assets (ROA)
21.1 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 1 Jul 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 30 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 30 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 16 Apr 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 7 Apr 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 30 Apr 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 31 Oct 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main

Rulings 3

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50089308 / 3
1 Sep 2023
 Amendment entry In force
1 Sep 2023
 PDF
Ä 50089308 / 2
6 Oct 2020
 Amendment entry In force
6 Oct 2020
 PDF
Ä 50089308
7 Mar 2018
 First entry In force
7 Mar 2018
 PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data